Previous Article | Next Article ![]()
Eukaryotic Cell, November 2008, p. 2004-2007, Vol. 7, No. 11
1535-9778/08/$08.00+0 doi:10.1128/EC.00142-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma 74078
Received 22 April 2008/ Accepted 20 August 2008
|
|
|---|
and brlAβ expression. RNAi was specific for brlAβ, but not brlA
, silencing, indicating brlA
regulation by brlAβ. |
|
|---|
and brlAβ (Fig. 1A). The brlAβ transcript begins at –851 and has an intron between –99 and +293 and extends to +2085. The brlA
transcript begins within the brlAβ intron at +1 and extends to +2085 (23).
![]() View larger version (14K): [in a new window] |
FIG. 1. brlA locus and RNAi construct. (A) The brlA locus consists of two overlapping transcriptional units, brlA and brlAβ. The top line represents the brlA genomic DNA (gDNA). The portion of the locus flanked by BamHI sites (–2902 to –404) used in the RNAi construct included only brlAβ. The line of the transcripts (mRNA) represents untranslated RNA, and the box represents translated mRNA. brlAβ has one intron (–99 to +293) where brlA transcription begins. (B) The RNAi construct consists of inverted repeats of inducible alcA promoters [alcA(p)] flanking brlAβ in a unique BamHI site. The RNAi construct also contains an argB marker for the nutritional selection of transformants.
|
A. nidulans strains RMS11 (pabaA1 yA2 argB::trpC veA1 trpC801) and LR191 (pyrG pabaA1 yA2 argB pyroA veA1) were transformed with the construct as previously described (26), except that germlings were digested with Driselase (Sigma) instead of Novozyme234. Eight primary transformants were obtained, and two of these RNAi strains, JB1 and JB3, were chosen for further analysis. The integration of the construct into the genomes was verified with PCR and Southern blot analysis (data not shown) of genomic DNA. Southern blots also verified that the native brlA gene was not disrupted by homologous recombination.
In submerged culture, A. nidulans conidiophore development is suppressed, but spores develop vegetatively to produce mature mycelia. Conidiophore development begins in a synchronized manner when the mycelia are plated and exposed to air (5, 6). The wild-type, JB1, and JB3 spores were inoculated in minimal medium (22) broth and shaken for 24 h at 250 rpm. Mycelia were harvested by filtration, washed thoroughly with sterile water, and plated on glucose and threonine (Fig. 2A). After 24 h of developmental induction, the wild type developed yellow-pigmented conidia on both glucose and threonine, but the RNAi strains developed conidia only on glucose (Fig. 2A). On threonine, JB1 displayed a brlA null phenotype, but JB3 displayed a brlA leaky phenotype that develops rudimentary vesicles and sterigmata (Fig. 2B and C). This indicated that brlA is silenced to various degrees when the RNAi strains develop on threonine, but it is not silenced on glucose.
![]() View larger version (58K): [in a new window] |
FIG. 2. Phenotypes of RNAi strains. (A) Plates that contained either glucose (G) or threonine (T) as the sole carbon source were scanned with a Microtek ScanMaker 4700. (B) Plates were photographed with a Canon Powershot A620 under a Nikon SMZ-U stereomicroscope at x60 magnification. (C) Tape mounts were taken from the plates and photographed under a Nikon TMS microscope at x1,000 magnification. These images show the wild type (WT) under both conditions and the RNAi strains (JB1 and JB3) on glucose with mature conidiophore development and viable conidia. The RNAi mutants on threonine show brlA phenotypes.
|
and brlAβ on threonine compared to that on glucose (data not shown). In order to quantify the level of change (n-fold) of the brlA
and brlAβ transcripts, real-time RT-PCR on an Applied Biosystems 7500 real-time PCR system was employed (Fig. 3A). For analysis, the threshold cycle (CT) value was set at 1.5, and 
CT calculations were performed relative to values for actin and the mean
CT. The changes (n-fold) in gene expression were derived from 10(–
CT/ln10/ln2), where the primer efficiency (ln10/ln2) was calculated experimentally for each primer set. In the wild type, brlA
and brlAβ expression was not reduced on threonine. In JB1, brlA expression on glucose is approximately equal to that of the wild type on glucose, but there is only a slightly detectable abundance of brlA
and brlAβ on threonine. JB3 had a large amount of brlA
and brlAβ on glucose, nearly fivefold more than the wild type, but brlA
and brlAβ expression on threonine was three- to fourfold less abundant than that on glucose. These experimental results imply that the expression of brlA is silenced in the RNAi strains on threonine. The silencing in JB1 is more drastic than the silencing in JB3, which corresponds to the respective brlA null and leaky phenotypes.
![]() View larger version (39K): [in a new window] |
FIG. 3. brlA expression and siRNA analysis. (A) Primers used in real-time RT-PCR were specific for brlA , brlAβ, and the overlapping portion of brlA and brlAβ (brlA β). The wild type (WT) had normal expression of brlA on both glucose (G) and threonine (T). JB1 had normal brlA expression on glucose but almost undetectable expression on threonine. JB3 had high levels of brlA expression on glucose but reduced expression on threonine. (B) siRNAs specific for brlAβ in the RNAi strains on threonine were detected. No siRNAs were detected in the wild-type or RNAi strains on glucose. Untreated probes (+) or probes treated with RNaseA/T1 (–) were used as controls. (C) No siRNAs were detected using a probe specific for the overlapping portion of brlA and brlAβ. This indicates that the RNAi mechanism is specifically targeting for brlAβ, not brlA . Low-molecular-weight (MW) RNA is shown to verify its integrity.
|
was undetectable. For siRNA analysis (Fig. 3B and C), sodium carbonate-treated probes (7) were used with a mirVana microRNA detection kit (Ambion). siRNAs specific for brlAβ (Fig. 3B) were present in the RNAi strains on threonine but not in the wild type or on glucose. No siRNAs were detected for the overlapping portion of brlA
and brlAβ (Fig. 3C). siRNAs were more abundant in JB1 than JB3, corresponding to the respective brlA null and leaky phenotypes. These blots verified that RNAi mechanisms are the direct cause of brlAβ silencing and that brlAβ, not brlA
, is the target of RNAi.
brlA regulates developmental genes such as abaA (2, 19), wetA (16), rodA (8, 24), and stuA (17). The most current models suggest that brlAβ initiates asexual development, since it is present in small quantities in vegetative cells, and brlA
continues the development through a feedback mechanism with abaA (3, 12, 13). Furthermore, in a brlAβ knockout mutant, brlA
expression was not detected after 12 h of developmental induction (23), and the overexpression of brlAβ induces the expression of brlA
even when abaA is not present (12). This evidence and our results strongly suggest that brlAβ plays a key role in regulating the expression of brlA
.
The novel RNAi construct serves as a powerful genetic tool, because RNAi is easily induced and any gene of interest may be cloned into the single BamHI site in either orientation. Problems associated with lethal knockouts of essential genes is circumvented, because these strains are isolated on glucose and then characterized by RNAi induction on threonine. Additionally, the one-step cloning of a gene in either orientation is advantageous over the currently popular use of inverted repeat transgenes, where the gene must be cloned twice in specific orientations to produce double-stranded hairpin RNA (10, 11, 21, 25).
Published ahead of print on 29 August 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»